PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19573576-6	2009	The sympathetic response was blocked by methyllycaconitine citrate, a selective alpha 7 nicotinic cholinergic receptor (nAchR) antagonist.	Methyllycaconitine citrate	40-66	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	120-125	
24289814-7	2014	In B6 mice, the alpha7 nicotinic acetylcholine receptor (nAChR)-selective agonist, PHA-543613, dose-dependently blocked nicotine CPP, which was restored using the alpha7 nAChR-selective antagonist, methyllycaconitine citrate (MLA).	Methyllycaconitine citrate	198-224	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	57-62	
19887306-7	2010	Pretreatment with methyllycaconitine citrate, a selective alpha7 nicotinic receptor antagonist, significantly attenuated cytisine-induced sympathetic response with little effect on the parasympathetic response.	Methyllycaconitine citrate	18-44	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	58-83	
29353067-5	2018	All effects of LXM-15 could be blocked by methyllycaconitine citrate (MLA, a selective alpha7 nicotinic receptor antagonist) or tropicamide (TRO, a selective M4 muscarinic receptor antagonist).	Methyllycaconitine citrate	42-68	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	87-112	
28656709-7	2017	Selective alpha7nAChR antagonists, such as methyllycaconitine citrate, or transient receptor potential ankyrin 1 (TRPA1) antagonists, such as HC-030031, significantly inhibited the amelioration of macrophage infiltration by ZSR.	Methyllycaconitine citrate	43-69	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	10-21	
34712695-4	2021	Nicotinic AChR-mediated effects of varenicline were investigated by using a non-selective nAChR antagonist mecamylamine hydrochloride and a selective alpha7nAChR antagonist methyllycaconitine citrate.	Methyllycaconitine citrate	173-199	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	150-161	
34055878-9	2021	Moreover, the therapeutic effects of EA were attenuated in mice treated with methyllycaconitine citrate, a selective alpha7nAChR antagonist.	Methyllycaconitine citrate	77-103	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	117-128